Genomic analysis of "microphenotypes" in epilepsy.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
01 2022
Historique:
revised: 22 06 2021
received: 09 04 2021
accepted: 23 07 2021
pubmed: 28 9 2021
medline: 8 4 2022
entrez: 27 9 2021
Statut: ppublish

Résumé

Large international consortia examining the genomic architecture of the epilepsies focus on large diagnostic subgroupings such as "all focal epilepsy" and "all genetic generalized epilepsy". In addition, phenotypic data are generally entered into these large discovery databases in a unidirectional manner at one point in time only. However, there are many smaller phenotypic subgroupings in epilepsy, many of which may have unique genomic risk factors. Such a subgrouping or "microphenotype" may be defined as an uncommon or rare phenotype that is well recognized by epileptologists and the epilepsy community, and which may or may not be formally recognized within the International League Against Epilepsy classification system. Here we examine the genetic structure of a number of such microphenotypes and report in particular on two interesting clinical phenotypes, Jeavons syndrome and pediatric status epilepticus. Although no single gene reached exome-wide statistical significance to be associated with any of the diagnostic categories, we observe enrichment of rare damaging variants in established epilepsy genes among Landau-Kleffner patients (GRIN2A) and pediatric status epilepticus patients (MECP2, SCN1A, SCN2A, SCN8A).

Identifiants

pubmed: 34569149
doi: 10.1002/ajmg.a.62505
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-146

Informations de copyright

© 2021 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Epi25 Collaborative. (2019). Ultra-rare genetic variation in the epilepsies: A whole-exome sequencing study of 17,606 individuals. Epi25 collaborative. American Journal of Human Genetics, 105(2), 267-282. https://doi.org/10.1016/j.ajhg.2019.05.020
Epi4K and EPGP Investigators, Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen, A. S., Berkovic, S. F., Cossette, P., Delanty, N., Dlugos, D., Eichler, E. E., Epstein, M. P., Glauser, T., Goldstein, D. B., Han, Y., Heinzen, E. L., Hitomi, Y., Howell, K. B., Johnson, M. R., Kuzniecky, R., Lowenstein, D. H., Lu, Y. F., … Winawer, M. R. (2013). De novo mutations in epilepstic encephalopathies. Nature, 501(7466), 217-221. https://doi.org/10.1038/nature12439
Epi4K Consortium, Berkovic, S., Cossette, P., Delanty, N., Dlugos, D., Eichler, E., Epstein, M., Glauser, T., Goldstein, D., Heinzen, E., Johnson, M. R., Kuzniecky, R., Lowenstein, D., Marson, T., Mefford, H., O'Brien, T., Ottman, R., Poduri, A., Scheffer, I., … Shianna, K. (2012). Epi4K: Gene discovery in 4,000 genomes. Epilepsia, 53(8), 1457-1467. https://doi.org/10.1111/j.1528-1167.2012.03511.x
Ernst, M. E., Baugh, E. H., Thomas, A., Bier, L., Lippa, N., Stong, N., Mulhern, M. S., Kushary, S., Akman, C. I., Heinzen, E. L., Yeh, R., Bi, W., Hanchard, N. A., Burrage, L. C., Leduc, M. S., JSC, C., Bend, R., Lyons, M. J., Lee, J. A., … Aggarwal, V. (2021). CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity. Epilepsia, 62(7), e103-e109. https://doi.org/10.1111/epi.16931
Hiraide, T., Nakashima, M., Yamoto, K., Fukuda, T., Kato, M., Ikeda, H., Sugie, Y., Aoto, K., Kaname, T., Nakabayashi, K., Ogata, T., Matsumoto, N., & Saitsu, H. (2018 Jan). De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism. Human Genetics, 137(1), 95-104. https://doi.org/10.1007/s00439-017-1863-y
International League Against Epilepsy Consortium on Complex Epilepsies. (2018). Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nature Communications, 9(1), 5269. https://doi.org/10.1038/s41467-018-07524-z
Jeavons, P. M. (1977). Nosological problems of myoclonic epilepsy in children and adolescence. Developmental Medicine and Child Neurology, 19, 3-8.
Leu, C., Stevelink, R., Smith, A. W., Goleva, S. B., Kanai, M., Ferguson, L., Campbell, C., Kamatani, Y., Okada, Y., Sisodiya, S. M., Cavalleri, G. L., Koeleman, B. P. C., Lerche, H., Jehi, L., Davis, L. K., Najm, I. M., Palotie, A., Daly, M. J., Busch, R. M., … Lal, D. (2019). Polygenic burden in focal and generalized epilepsies. Brain, 142(11), 3473-3481. https://doi.org/10.1093/brain/awz292
Petrovski, S., Wang, Q., Heinzen, E. L., Allen, A. S., & Goldstein, D. B. (2013). Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genetics, 9(8), e1003709. https://doi.org/10.1371/journal.pgen.1003709
Sánchez Fernández, I., Abend, N. S., Agadi, S., An, S., Arya, R., Carpenter, J. L., Chapman, K. E., Gaillard, W. D., Glauser, T. A., Goldstein, D. B., Goldstein, J. L., Goodkin, H. P., Hahn, C. D., Heinzen, E. L., Mikati, M. A., Peariso, K., Pestian, J. P., Ream, M., Riviello Jr, J. J., … Pediatric Status Epilepticus Research Group (pSERG). (2014). Gaps and opportunities in refractory status epilepticus research in children: A multi-center approach by the pediatric status epilepticus. Seizure, 23(2), 87-97. https://doi.org/10.1016/j.seizure.2013.10.004
Selvam, P., Jain, A., Cheema, A., Atwal, H., Forghani, I., & Atwal, P. S. (2021). Poirier-Bienvenu neurodevelopment syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth. American Journal of Medical Genetics, 185, 539-543.
Sen, A., Dugan, P., Perucca, P., Costello, D., Choi, H., Bazil, C., Radtke, R., Andrade, D., Depondt, C., Heavin, S., Adcock, J., Pickrell, W. O., McGinty, R. N., Nascimento, F., Smith, P., Rees, M. I., Kwan, P., O'Brien, T. J., Goldstein, D., & Delanty, N. (2018). The phenotype of bilateral hippocampal sclerosis and its management in "real life" clinical settings. Epilepsia, 59(7), 1410-1420. https://doi.org/10.1111/epi.14436

Auteurs

Kate Stanley (K)

Columbia Presbyterian Medical Center, New York, New York, USA.

Joseph Hostyk (J)

Institute for Genomic Medicine, Columbia Presbyterian Medical Center, New York, New York, USA.

Linh Tran (L)

Duke University School of Medicine, Durham, North Carolina, USA.

Marta Amengual-Gual (M)

Division of Epilepsy and Clinical Neurophysiology, Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

Patricia Dugan (P)

Department of Neurology, NYU Langone Medical Center, New York, New York, USA.

Justice Clark (J)

Boston Children's Hospital, Boston, Massachusetts, USA.

Hyunmi Choi (H)

Department of Neurology, Columbia Presbyterian Medical Center, New York, New York, USA.

Dmitry Tchapyjnikov (D)

Department of Medicine, Duke University, Durham, North Carolina, USA.

Piero Perucca (P)

Department of Neurology, Faculty of Medicine Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

Cecilia Fernandes (C)

Duke University School of Medicine, Durham, North Carolina, USA.

Danielle Andrade (D)

Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada.

Orrin Devinsky (O)

Department of Neurology, School of Medicine, New York University, New York, New York, USA.

Gianpiero L Cavalleri (GL)

School of Pharmacy and Biomedical Sciences, and FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.

Chantal Depondt (C)

Erasmus Hospital, Bruxelles, Belgium.

Arjune Sen (A)

Department of Clinical Neurosciences - Neurology, University of Oxford Nuffield, Oxford, UK.

Terence O'Brien (T)

Department of Medicine, Faculty of Medicine Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

Erin Heinzen (E)

Pharmacy and Genetics, University of North Carolina System, Chapel Hill, North Carolina, USA.

Tobias Loddenkemper (T)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

David B Goldstein (DB)

Institute for Genomic Medicine, Columbia Presbyterian Medical Center, New York, New York, USA.

Mohamed A Mikati (MA)

Division of Pediatric Neurology and Developmental Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Norman Delanty (N)

Department of Neurology, Beaumont Hospital, School of Pharmacy and Biomedical Sciences, and FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH